These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1739287)

  • 1. Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases.
    Villada G; Roujeau JC; Clérici T; Bourgault I; Revuz J
    Arch Dermatol; 1992 Jan; 128(1):50-3. PubMed ID: 1739287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
    Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM
    J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological differential diagnosis of drug-induced toxic epidermal necrolysis (Lyell's syndrome) and acute graft-versus-host reaction.
    Paquet P; Arrese JE; Beguin Y; Piérard GE
    Curr Top Pathol; 2001; 94():49-63. PubMed ID: 11443887
    [No Abstract]   [Full Text] [Related]  

  • 4. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
    J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of CD14+ CD16+ monocyte lineage cells in the epidermal damage of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Tohyama M; Watanabe H; Murakami S; Shirakata Y; Sayama K; Iijima M; Hashimoto K
    Br J Dermatol; 2012 Feb; 166(2):322-30. PubMed ID: 21936856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions.
    de Boer OJ; van der Loos CM; Hamerlinck F; Bos JD; Das PK
    Arch Dermatol Res; 1994; 286(2):87-96. PubMed ID: 7512323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidermal necrolysis: mechanisms of keratinocyte apoptosis].
    Roujeau JC; Gélard K; Bensussan A
    Med Sci (Paris); 2006 Feb; 22(2):188-91. PubMed ID: 16457761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotyping of skin cells during healing of suction blister injury.
    Reusch MK; Mansbridge JN; Nickoloff BJ; Morhenn VB
    Dermatologica; 1991; 183(3):179-83. PubMed ID: 1683839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of epidermal Langerhans' cells and endothelial cell HLA-DR antigens in the skin in progressive systemic sclerosis.
    Andrews BS; Friou GJ; Barr RJ; Mirick GR; Berman M; Sandborg C; Ross PA
    J Rheumatol; 1986 Apr; 13(2):341-8. PubMed ID: 2941574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal Langerhans cells, dermal dendritic cells, and keratinocytes in viral lesions of skin and mucous membranes: an immunohistochemical study.
    Drijkoningen M; De Wolf-Peeters C; Degreef H; Desmet V
    Arch Dermatol Res; 1988; 280(4):220-7. PubMed ID: 2466441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans' cells and lymphocytic infiltrate in AIDS-associated Kaposi's sarcoma. An immunohistochemical study.
    Valcuende-Cavero F; Febrer-Bosch MI; Castells-Rodellas A
    Acta Derm Venereol; 1994 May; 74(3):183-7. PubMed ID: 7521102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Langerhans cells in prurigo nodularis investigated by HLA-DR and S-100 immunofluorescence double staining.
    Johansson O; Liang Y; Heilborn JD; Marcusson JA
    J Dermatol Sci; 1998 May; 17(1):24-32. PubMed ID: 9651825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistologic studies in pityriasis rosea. Evidence for cellular immune reaction in the lesional epidermis.
    Aiba S; Tagami H
    Arch Dermatol; 1985 Jun; 121(6):761-5. PubMed ID: 3890762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acrodermatitis chronic atrophicans: a chronic T-cell-mediated immune reaction against Borrelia burgdorferi? Clinical, histologic, and immunohistochemical study of five cases.
    Buechner SA; Rufli T; Erb P
    J Am Acad Dermatol; 1993 Mar; 28(3):399-405. PubMed ID: 8095272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study of epidermal Langerhans cells and dermal dendritic cells in benign and malignant skin lesions characterized by a dermal lymphoid infiltrate consisting either of B-cells or T-cells.
    Drijkoningen M; De Wolf-Peeters C; Snauwaert J; De Greef H; Desmet V
    Virchows Arch A Pathol Anat Histopathol; 1987; 411(4):337-43. PubMed ID: 2442885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ characterization of cellular infiltrates in lupus vulgaris indicates lesional T-cell activation.
    Ramesh V; Samuel B; Misra RS; Nath I
    Arch Dermatol; 1990 Mar; 126(3):331-5. PubMed ID: 1689989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HLA-DR and OKT6 antigens on keratinocytes and dendritic cells in pemphigus.
    Picut C; Meunier J; Lee C; Lewis R
    Arch Dermatol Res; 1987; 279(8):516-20. PubMed ID: 2449139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse intraepidermal deposition of immunoreactants on direct immunofluorescence: a clue to the early diagnosis of epidermal necrolysis.
    King T; Helm TN; Valenzuela R; Bergfeld WF
    Int J Dermatol; 1994 Sep; 33(9):634-6. PubMed ID: 8002159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of CD1a, HLA-DR, and HLA class I expression on viable human Langerhans cells and keratinocytes.
    Meunier L; Vian L; Lagoueyte C; Lavabre-Bertrand T; Duperray C; Meynadier J; Cano JP
    Cytometry; 1996 Dec; 26(4):260-4. PubMed ID: 8979024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stevens-Johnson syndrome/toxic epidermal necrolysis mouse model generated by using PBMCs and the skin of patients.
    Saito N; Yoshioka N; Abe R; Qiao H; Fujita Y; Hoshina D; Suto A; Kase S; Kitaichi N; Ozaki M; Shimizu H
    J Allergy Clin Immunol; 2013 Feb; 131(2):434-41.e1-9. PubMed ID: 23111236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.